PR2 Immunotherapy Shows Promise in DLBCL Cases
In a remarkable advance within the realm of immunotherapy, a new study published in the journal "Annals of Hematology" sheds ...
In a remarkable advance within the realm of immunotherapy, a new study published in the journal "Annals of Hematology" sheds ...
In a groundbreaking study, researchers have harnessed the potential of bioorthogonal chemistry to develop tumour-specific proteolysis-targeting chimeras (PROTACs) and nanoparticles ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine